Dr Reddys Laboratories Ltd
About
Dr Reddy’s, one of India's leading drug manufacturers and suppliers, caters to 42 markets all over the globe. The company's key regions include the USA, Russia, Europe and the Commonwealth of Independent States. Dr Reddy's functions with three verticals - pharmaceutical services and active ingredients (PSAI), global generics and proprietary products- that offer a plethora of products ranging from APIs and generics to biosimilars and differentiated formulations. The leading revenue generator is the global generics segment in North America, closely followed by the PSAI segment. The company also invests in advancing pharmaceutical research and has established 8 global R&D Centres dedicated to solving unmet medical needs. Among these, the Integrated Product Development Organisation in Bachupally, Telangana is the most significant centre featuring specialised laboratories that drive the manufacturing of over 1000 product lines.
Featured In Fortune India Ranking
Financial Data 2024
Fortune India Coverage
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 29601 15.2% | 25691 14.4% | 22454 11.3% | 20177 11.1% | 18170 12.8% | 16105 11.2% | 14478 -0.1% | 14491 -9.2% | 15959 4.0% | 15353 10.4% | 13905 14.4% | 12151 20.3% | 10099 32.0% | 7652 7.7% | 7108 0.2% | 7095 - |
| Net Operating Income (INR Cr) | 28011 13.54% | 24670 14.50% | 21545 13.11% | 19048 8.74% | 17517 13.39% | 15448 8.17% | 14281 0.60% | 14196 -8.81% | 15568 3.63% | 15023 11.99% | 13415 13.38% | 11833 20.56% | 9815 32.00% | 7435 5.75% | 7031 2.46% | 6862 38.26% |
| Profit (INR Cr) | 5578 23.8% | 4507 106.5% | 2183 11.8% | 1952 -3.7% | 2026 3.9% | 1950 106.0% | 947 -26.7% | 1292 -39.4% | 2131 -8.8% | 2336 19.0% | 1963 28.6% | 1527 17.4% | 1301 30.2% | 999 184.2% | 352 - | -917 - |
| Assets (INR Cr) | 30595 23.1% | 24856 9.1% | 22790 9.1% | 20885 15.5% | 18089 -0.4% | 18159 0.8% | 18018 2.3% | 17608 8.3% | 16266 12.0% | 14518 16.0% | 12517 23.5% | 10138 22.1% | 8306 28.0% | 6488 23.3% | 5261 -4.8% | 5524 - |
| Net Worth (INR Cr) | 28255 21.3% | 23286 21.2% | 19212 8.9% | 17642 13.1% | 15599 11.2% | 14024 11.6% | 12572 2.5% | 12262 -2.5% | 12570 27.6% | 9853 25.3% | 7865 23.5% | 6369 27.7% | 4989 23.7% | 4032 6.8% | 3777 7.1% | 3526 -21.6% |
| Employee Cost (INR Cr) | 5030 8.3% | 4647 19.6% | 3886 7.1% | 3630 7.4% | 3380 0.7% | 3356 4.4% | 3215 3.5% | 3107 -0.3% | 3117 5.9% | 2945 19.0% | 2475 28.4% | 1929 21.2% | 1591 24.5% | 1278 9.9% | 1163 19.7% | 972 - |
| Interest Cost (INR Cr) | 171 | 143 | 96 | 97 | 98 | 89 | 79 | 63 | 83 | 108 | 127 | 100 | 114 | 32 | 39 | 108 |
| Cash & Bank Balance (INR Cr) | 1728 | 1730 | 2419 | 2079 | 205 | 223 | 264 | 387 | 492 | 1872 | 2301 | 2017 | 1606 | 575 | 660 | 562 |
| Total Debt (INR Cr) | 2002 | 1347 | 3385 | 3031 | 2210 | 3838 | 5071 | 4919 | 3352 | 4314 | 4477 | 3682 | 3234 | 2371 | 1484 | 1998 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 18.8% | 17.5% | 9.7% | 9.7% | 11.2% | 12.1% | 6.5% | 8.9% | 13.4% | 15.2% | 14.1% | 12.6% | 12.9% | 13.1% | 5.0% | - |
| Profit As % Of Assets | 18.2% | 18.1% | 9.6% | 9.3% | 11.2% | 10.7% | 5.3% | 7.3% | 13.1% | 16.1% | 15.7% | 15.1% | 15.7% | 15.4% | 6.7% | - |
| Profit As % Of Networth | 19.7% | 19.4% | 11.4% | 11.1% | 13.0% | 13.9% | 7.5% | 10.5% | 17.0% | 23.7% | 25.0% | 24.0% | 26.1% | 24.8% | 9.3% | - |
| Interest Cost to EBITDA % | 2.2% | 2.3% | 2.5% | 2.5% | 4.0% | 2.8% | 3.4% | 2.6% | 2.3% | 3.1% | 3.9% | 3.8% | 5.0% | 2.1% | 4.0% | - |
| Debt to Equity Ratio | 0.07 | 0.06 | 0.18 | 0.17 | 0.14 | 0.27 | 0.40 | 0.40 | 0.27 | 0.44 | 0.57 | 0.58 | 0.65 | 0.59 | 0.39 | 0.57 |
| RONW | 21.6% | 21.2% | 11.8% | 11.7% | 13.7% | 14.7% | 7.4% | 10.1% | 18.8% | 26.4% | 27.6% | 26.9% | 28.8% | 25.6% | 15.6% | - |
| ROCE | 26.6% | 26.0% | 14.5% | 15.3% | 11.0% | 13.4% | 8.0% | 9.6% | 19.1% | 22.3% | 24.5% | 24.6% | 25.9% | 20.7% | 20.7% | 15.1% |